Cell Therapy 2.0 – warts and all

by David Kent | Mar 16, 2015

> The last 15 years of stem cell research have been full of hope and promises – some of it delivered upon, most of it not quite there yet, and some of it miserably failed. I guess that is to be expected in a highly experimental area of medicine, but one of the most...

Right Turn: Super Cells in Newcastle

by Lisa Willemse | Mar 13, 2015

> Super Cells has grown wings and flown over to Newcastle. Yes, I know, you’re struck dumb at the improbability of this terrible metaphor, but far less than I am: having reviewed every word, every animation, every image, every concept of this exhibit,...

Hot off the press: DNA-based bioprinting of tissues

by Guest | Mar 11, 2015

. By S. Amanda Ali, PhD What do biomaterials mean to you? For this orthopaedic scientist, the first thing that comes to mind is the total joint replacement: artificial knees, hips and shoulders made from a variety of materials to reproduce joint function and suit each...

Biomaterials 101– A fate-twister

by Guest | Mar 10, 2015

  By guest blogger Jane Cheung With contributions from Casandra Gardner, PhD and Joanna Fromstein P.Eng (Centre for Commercialization of Regenerative Medicine) “Fate has brought us here.” “This is my destiny.” We often read or hear these phrases in books or...

Right Turn: Commercializing iPSCs – Infographics

by Stacey Johnson | Mar 6, 2015

. The beauty of an infographic (or two) is it speaks for itself.   Shared with permission of BioInformant: http://www.bioinformant.com/   Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We...

How online outreach adds value to scientific research

by Nick Dragojlovic | Mar 4, 2015

> Scientists: I have some questions. Have you ever written a blog post about your field? Tweeted a link to a new scientific publication? Joined a forum discussion about the latest research? As it turns out, your likelihood of answering “yes” to one or more of these...

OMICS Workshop: An introduction into systemic tools for diverse cell populations

by Guest | Mar 3, 2015

Guest post by Anastassia Voronova Sequencing platforms and techniques are undergoing a revolutionary and transformational progress. As a stem cell researcher, I value the opportunity for continued professional education to maintain a grip on the latest technologies....

Right Turn: A lesson in blood development

by Peter Raaymakers | Feb 27, 2015

Hematopoiesis is a long word, but in essence it describes a pretty straight-forward concept: The formation of our blood system, including all of its components. It’s a multi-step process beginning with stem cells and ending with mature, specialized ones like red...

Regenerative Medicine Deal Review: January

by Mark Curtis | Feb 23, 2015

. Welcome to your deal review for the month of January. There was a mixed bag of news last month, which included financing activity, industry partnerships and research collaborations. The cell therapy tools industry was front and centre as NeoStem and Invetech struck...

Right Turn: Why Janet Rossant is optimistic about the future of regenerative medicine

by Stacey Johnson | Feb 20, 2015

. If you haven’t heard the name Janet Rossant, my guess is that you aren’t part of the stem cell community or you spend a little too much time in the lab. Dr. Rossant is Chief of Research at the Hospital for Sick Children in Toronto, Canada and she leads the new...